|
WO2021080927A2
|
|
Sorting algorithm for substance handling robots
|
|
US2021115141A1
|
|
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma
|
|
WO2021072298A1
|
|
Pd-1 targeted il-15/il-15ralpha fc fusion proteins with improved properties
|
|
WO2021062085A1
|
|
Dosing for treatment with anti-tigit and anti-pd-l1 antagonist antibodies
|
|
US2021098082A1
|
|
Tumor phenotype prediction using genomic analyses indicative of digital-pathology metrics
|
|
WO2021055694A1
|
|
Dosing for anti-tryptase antibodies
|
|
WO2021055577A2
|
|
Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods of use
|
|
WO2021050654A1
|
|
Process for the preparation of a medicament containing an oxepane ring.
|
|
WO2021050645A1
|
|
Compositions and methods of treating lupus nephritis
|
|
WO2021046159A1
|
|
Cd8 binding agents and uses thereof
|
|
WO2021041834A1
|
|
Developing an efficient hybridoma platform for therapeutic antibody discovery
|
|
WO2021030629A1
|
|
Three dimensional object segmentation of medical images localized with object detection
|
|
WO2021030248A1
|
|
Treatment of breast cancer using combination therapies comprising an atp competitive akt inhibitor, a cdk4/6 inhibitor, and fulvestrant
|
|
WO2021026039A1
|
|
Using deep learning to process images of the eye to predict visual acuity
|
|
WO2021025940A1
|
|
Prediction of side-chain degradation in polymers through physics based simulations
|
|
WO2021025951A1
|
|
Multipole moment based coarse grained representation of antibody electrostatics
|
|
US2021023176A1
|
|
DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 Fc FUSION PROTEINS
|
|
WO2021016502A1
|
|
Detecting neurally programmed tumors using expression data
|
|
US2021015920A1
|
|
Composition and methods for stabilizing liquid protein formulations
|
|
WO2020264253A1
|
|
Randomized configuration targeted integration of nucleic acids
|
